Related Experiment Video
Updated: Mar 13, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
PET-CT Post-Hepatic Radiation Changes in Gastroesophageal Adenocarcinoma
Don Nguyen1, Rishi Maheshwary, Anuj Rajput
1From the *Diagnostic Radiology, Allegheny General Hospital, Pittsburgh, PA; and †Diagnostic Radiology, Stony Brook University, Stony Brook, NY; ‡Family Medicine and §Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA.
Abstract:
Gastroesophageal junction adenocarcinoma on esophagogastroduodenoscopy biopsy. Initial PET-CT showed no definite evidence of distant metastatic disease. One month after radiation treatment, repeat PET-CT showed interval decrease in size of gastroesophageal mass but new multifocal FDG avidity in the caudate and left hepatic lobes. Correlation with contrast-enhanced CT and US images was negative, making metastasis less likely. Ultrasound-guided biopsy confirmed radiation-induced hepatitis, which caused false positively increased FDG uptake from inflammatory changes.

